The share of HIV-positive tuberculosis patients on antiretroviral therapy (ART) in Thailand has shown a notable upward trend. As of 2023, it stands at 74 units. The years leading up to 2023 have seen an overall positive progression despite some fluctuation between 2015 and 2017.
Year-on-year variations indicate a steady increase: 2021 saw a 1.4% rise from 2020, and 2022 experienced a 1.4% increase from 2021. The CAGR over the last five years stands at 1.3%, highlighting consistent annual growth despite minor downturns in earlier years.
Future trends suggest a continual rise, with forecasts for 2028 estimating the share to reach 80 units. The projected 5-year growth rate of 6.67% affirms the commitment to increasing ART coverage among co-infected patients. Trends to watch for include advancements in healthcare policies, funding for HIV and TB programs, and improvements in diagnostic and treatment modalities.
